0 likes | 2 Vues
Tirzepatide operates on a dual-action mechanism that targets metabolic regulation in ways previously unseen in the pharmacological landscape. As a combined agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, it enhances the body's natural ability to regulate blood sugar and decrease appetite. The synergy between these two pathways is crucial, as it not only aids in weight reduction but also improves glycemic control. Visit: https://pommiermedspa.com/semaglutide-and-tirzepatide/
E N D